SIFI Reports Detailed Positive Results and New Data from the Completed Phase 3 Trial of AKANTIOR® in Patients with Acanthamoeba Keratitis presented at the American Academy of Ophthalmology Annual Meeting in Chicago : vimarsana.com

SIFI Reports Detailed Positive Results and New Data from the Completed Phase 3 Trial of AKANTIOR® in Patients with Acanthamoeba Keratitis presented at the American Academy of Ophthalmology Annual Meeting in Chicago

SIFI Reports Detailed Positive Results and New Data from the Completed Phase 3 Trial of AKANTIOR® in Patients with Acanthamoeba Keratitis presented at the American Academy of Ophthalmology Annual Meeting in Chicago
laragione.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laragione.eu Daily Mail and Mail on Sunday newspapers.

Related Keywords

Mexico , United States , United Kingdom , Italy , France , Spain , Turkey , Romania , Chicago , Illinois , American , British , John Dart , Vincenzo Papa , European Commission , Drug Administration , American Academy Of Ophthalmology , Early Access Program , Company Marketing Authorization Application , Vincenzo Papahead Of Scientific Affairs , University College London Institute Of Ophthalmology , European Medicines Agency , Head Of Scientific Affairs , Professor John Dart , Principal Investigator , American Academy , Annual Meeting , Retrospective Study , University College London Institute , New Drug Application , Marketing Authorization Application , Scientific Affairs , Jelle Kleijnglobal Head , Scientific Contact , Vincenzo Papahead ,